Grace Life-tech Holdings Limited AI Stock Analysis
Want to see HK:2112 full AI Analyst Report?
Grace Life-tech Holdings Limited (2112) AI Stock Analysis
Grace Life-tech Holdings Limited
(HKEX:2112)
The score is driven primarily by severe financial weakness, including negative equity, sustained losses, declining revenue, and deteriorating cash flow. Bearish technical trends and a negative P/E provide additional downside signals, while oversold momentum does not materially improve the overall risk profile.
Grace Life-tech Holdings Limited (2112) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 34.50M
- Dividend Yield
- ―
- Average Volume (3M)
- 1.09M
- Price to Earnings (P/E)
- -0.2
- Beta (1Y)
- 0.63
- Revenue Growth
- -45.65%
- EPS Growth
- 29.13%
- Country
- Hong Kong
- Employees
- 46
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Industrial - Distribution
Grace Life-tech Holdings Limited Business Overview & Revenue Model
Company Description
Grace Life-tech Holdings Limited, an investment holding company, engages in the research, development, and application of plant stem cell technology. It is also involved in the provision of health solutions and product sales in Hong Kong, the People’...
Grace Life-tech Holdings Limited Financial Statement Overview
Summary
Severe financial distress: revenue has declined sharply, losses remain persistent, equity is deeply negative, debt is high, and operating cash flow is negative.
Income Statement
12Very NegativeBalance Sheet
8Very NegativeCash Flow
15Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.78M | 13.06M | 13.76M | 27.25M | 32.35M | 23.98M |
| Gross Profit | 1.18M | 1.48M | 2.17M | 2.85M | 2.54M | 164.00K |
| EBITDA | -8.00M | -7.50M | -30.49M | -23.74M | -42.55M | -44.21M |
| Net Income | -27.50M | -15.44M | -48.13M | -39.57M | -55.74M | -57.01M |
Balance Sheet | ||||||
| Total Assets | 77.60M | 75.50M | 79.80M | 108.95M | 133.56M | 173.13M |
| Cash, Cash Equivalents and Short-Term Investments | 129.98K | 358.95K | 255.00K | 135.00K | 187.00K | 1.19M |
| Total Debt | 161.26M | 148.27M | 193.26M | 121.04M | 171.57M | 166.50M |
| Total Liabilities | 271.23M | 257.10M | 247.29M | 228.85M | 213.88M | 197.41M |
| Stockholders Equity | -193.43M | -181.42M | -167.40M | -119.90M | -80.32M | -24.27M |
Cash Flow | ||||||
| Free Cash Flow | -4.43M | -372.55K | -78.00K | -53.00K | -1.01M | 1.10M |
| Operating Cash Flow | -4.43M | -372.55K | -75.00K | -27.00K | -1.00M | 1.41M |
| Investing Cash Flow | 0 | 0 | -3,000 | -26.00K | -2,000 | -303.00K |
| Financing Cash Flow | 4.48M | 488.72K | 193.00K | 0 | 0 | -12.00K |
Grace Life-tech Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2112, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 7.59 is Positive, neither overbought nor oversold. The STOCH value of 7.98 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2112.
Grace Life-tech Holdings Limited Peers Comparison
Overall Rating
HK:060958Neutral
HK:030155Neutral
HK:066043Neutral
HK:818940Underperform
HK:211237.75Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 58Neutral | HKD 821.32M | 13.99 | 2.08% | 3.19% | 16.60% | -12.13% | |
| 55Neutral | HKD 3.73B | -201.30 | -8.09% | ― | 3.15% | 50.74% | |
| 43Neutral | HKD 126.82M | 0.10 | 19.83% | ― | 7.28% | ― | |
| 40Underperform | HKD 211.26M | -9.20 | -634.56% | ― | 53.32% | -122.35% | |
| 38Underperform | HKD 34.50M | -0.15 | 14.68% | ― | -45.65% | 29.13% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2112 | Grace Life-tech Holdings Limited | 0.02 | -0.04 | -63.93% | |
| HK:8189 | Tianjin TEDA Biomedical Engineering Co. Ltd. Class H | 0.11 | -0.27 | -71.73% | |
| HK:0609 | Tiande Chemical Holdings Limited | 0.94 | -0.43 | -31.40% | |
| HK:0301 | SANVO Fine Chemicals Group Limited | 7.95 | 6.49 | 444.18% | |
| HK:0660 | Wai Chun Bio-Technology Ltd. | 0.33 | 0.13 | 63.37% | |
| HK:2565 | PegBio Co., Ltd. Class H | 2.23 | -63.27 | -96.60% |
Grace Life-tech Holdings Limited Corporate Events
Grace Life-tech discloses receivers appointed over 752,000,000 shares
Grace Life-tech Holdings disclosed that an independent third-party institution serving as lender to Cosmo Field appointed Koo Chi Ho Andrew and Lui Yee Lin as joint and several receivers over 752,000,000 shares held by Cosmo Field on 23 October 2026....
Grace Life-tech Publishes 2026 Interim Results Amid Ongoing Restructuring
Grace Life-tech Holdings Limited has released its unaudited interim results for the six months ended 30 June 2026, fulfilling Hong Kong listing requirements despite being under restructuring with joint provisional liquidators in place. The interim re...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 19, 2026
